4.05

2.06% -0.07

Kyverna Therapeutics Inc (KYTX)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$4.12

Offen:

$4.17

24-Stunden-Volumen:

195.84K

Relative Volume:

0.59

Marktkapitalisierung:

$177.87M

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

EPS:

Netto-Cashflow:

1W Leistung:

-15.94%

1M Leistung:

-22.40%

6M Leistung:

-70.55%

1J Leistung:

+0.00%

1-Tages-Spanne:

$3.97

$4.17

1-Wochen-Bereich:

$3.94

$4.85

52-Wochen-Spanne:

$3.94

$30.60

Kyverna Therapeutics Inc Stock (KYTX) Company Profile

Firmenname

Kyverna Therapeutics Inc

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

(510) 626-8331

Adresse

5980 HORTON STREET, EMERYVILLE

Mitarbeiter

119

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

KYTX's Discussions on Twitter

Vergleichen Sie KYTX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KYTX	4.03	177.87M	0	0	0	0.00
VRTX	450.61	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	749.05	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	589.59	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.41	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	106.82	24.89B	3.30B	-501.07M	1.03B	11.54

Kyverna Therapeutics Inc Aktie (KYTX) Neueste Nachrichten

02:13 AM

Kyverna stock plunges 28% amid data update on lead drug - MSN

02:13 AM

Nov 20, 2024

Kyverna Therapeutics (NASDAQ:KYTX) Price Target Cut to $6.00 by Analysts at HC Wainwright - MarketBeat

Nov 20, 2024

Kyverna stock maintains Neutral rating as analyst revises outlook amid higher costs - Investing.com UK

Nov 20, 2024

Nov 18, 2024

What is Leerink Partnrs’ Forecast for KYTX FY2024 Earnings? - Defense World

Nov 18, 2024

Nov 17, 2024

institutional investors of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) must be disappointed after last week's 18% drop - Yahoo Finance

Nov 17, 2024

Wells Fargo & Company Lowers Kyverna Therapeutics (NASDAQ:KYTX) Price Target to $24.00 - Defense World

Nov 17, 2024

Nov 14, 2024

Kyverna's CAR T-Cell Therapy Shows Promising Results in Lupus Nephritis Treatment | KYTX Stock News - StockTitan

Nov 14, 2024

Creative Planning Acquires Shares of 11,028 Kyverna Therapeutics, Inc. (NASDAQ:KYTX) - Defense World

Nov 14, 2024

Nov 13, 2024

Kyverna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results - StreetInsider.com

Nov 13, 2024

Nov 09, 2024

(KYTX) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 09, 2024

Nov 08, 2024

Analysts Set Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Price Target at $28.71 - Defense World

Nov 08, 2024

Nov 05, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Nov 05, 2024

Oct 30, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Short Interest Up 9.7% in October - MarketBeat

Oct 30, 2024

Oct 29, 2024

(KYTX) Trading Report - Stock Traders Daily

Oct 29, 2024

Oct 27, 2024

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Shares Purchased by Novo Holdings A S - MarketBeat

Oct 27, 2024

Oct 24, 2024

Kyverna Therapeutics to Participate in Upcoming September Invest - GuruFocus.com

Oct 24, 2024

Oct 22, 2024

Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

Oct 22, 2024

Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ - GlobeNewswire

Oct 22, 2024

Oct 21, 2024

Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors - cnhinews.com

Oct 21, 2024

Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors | KYTX Stock News - StockTitan

Oct 21, 2024

Oct 19, 2024

Kyverna Therapeutics (KYTX): Leading Nano Cap with Promising CAR T-Cell Therapy - Insider Monkey

Oct 19, 2024

Oct 18, 2024

(KYTX) Technical Data - Stock Traders Daily

Oct 18, 2024

Oct 17, 2024

500: Something went wrong - Investing.com

Oct 17, 2024

JPMorgan bullish on Kyverna Therapeutics stock amid CAR-T expansion potential - Investing.com UK

Oct 17, 2024

7 Best Nano Cap Stocks To Invest In - Insider Monkey

Oct 17, 2024

Oct 15, 2024

The Kyverna Therapeutics Inc. (KYTX) had a good session last reading, didn’t it? - US Post News

Oct 15, 2024

Oct 14, 2024